遺伝子パネルの世界市場:予測及び分析 2020-2024

Technavioが発行した調査報告書(IRTNTR40613)
◆英語タイトル:Gene Panel Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR40613
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年12月
◆ページ数:149
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

本レポートは、遺伝子パネルの市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別(小パネルテスト、大パネルテスト)分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。
・エグゼクティブサマリー
・レポートの範囲
・市場状況
・市場規模
・ファイブフォース分析
・遺伝子パネルの世界市場:製品別(小パネルテスト、大パネルテスト)
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因と課題
・市場動向
・企業状況
・企業分析
【レポートの概要】

Global Gene Panel Market: About this market
Technavio’s gene panel market analysis considers sales from small panel testing and large panel testing products. Our study also finds the sales of gene panels in Asia, Europe, North America, and ROW. In 2019, the small panel testing segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising need to identify a known gene mutation will play a significant role in the small panel testing segment to maintain its market position. Also, our global gene panel market report looks at factors such as the growing use of gene panels in cancer-targeted therapies, increasing the number of people with genetic disorders, and decreasing the cost of NGS gene panel tests. However, challenges in implementing large NGS gene panels, lack of effective treatment for several genetic mutations, and the growing complexity of gene panel tests may hamper the growth of the gene panel industry over the forecast period.

Global Gene Panel Market: Overview
Growing use of gene panels in cancer-targeted therapies
Pharmaceutical companies are investing heavily in research activities to develop targeted therapies for the treatment of cancer. This is driving the demand for gene panels as they are used in the development of targeted therapies for cancer. Gene panel testing provides a wide range of benefits such as providing the genetic basis of an individual’s response to therapy. NGS-based gene panel tests are becoming popular as the first choice for cancer care as they are cost-effective, provide genomic data in a brief time, and examine only clinically important genes. This is driving the use of gene panels to evaluate effective treatments for cancer, which will lead to the expansion of the global gene panel market at a CAGR of about 18% during the forecast period.
Rising use of direct-to-consumer tests
The global gene panel market is expected to benefit from the increase in the use of direct-to-consumer tests. In this method, commercial laboratories provide genetic testing directly to consumers without the involvement of a healthcare professional or an authorization for payment by a third-party payer. The easy access and the increasingly affordable options associated with direct-to-consumer genomic testing have helped the technique gain significant popularity over the recent years. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global gene panel market during the forecast period 2020-2024, click here.

Competitive Landscape
With the presence of a few major players, the global gene panel market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading gene panel manufacturers, that include Agilent Technologies Inc., ArcherDx Inc., BGI Genomics Co. Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GENEWIZ Inc., Novogene Corp., Personalis Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.
Also, the gene panel market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value Chain Analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Small panel testing – Market size and forecast 2019-2024
• Large panel testing – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing number of collaborations
• Rising use of direct-to-consumer tests
• Use of gene panels to identify potential side effects in patients
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies Inc.
• ArcherDx Inc.
• BGI Genomics Co. Ltd.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• GENEWIZ Inc.
• Novogene Corp.
• Personalis Inc.
• QIAGEN NV
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key product offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small panel testing – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Small panel testing – Year-over-year growth 2020-2024 (%)
Exhibit 22: Large panel testing – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Large panel testing – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Agilent Technologies Inc. – Vendor overview
Exhibit 45: Agilent Technologies Inc. – Business segments
Exhibit 46: Agilent Technologies Inc. – Organizational developments
Exhibit 47: Agilent Technologies Inc. – Geographic focus
Exhibit 48: Agilent Technologies Inc. – Segment focus
Exhibit 49: Agilent Technologies Inc. – Key offerings
Exhibit 50: ArcherDx Inc. – Vendor overview
Exhibit 51: ArcherDx Inc. – Product segments
Exhibit 52: ArcherDx Inc. – Organizational developments
Exhibit 53: ArcherDx Inc. – Key offerings
Exhibit 54: BGI Genomics Co. Ltd. – Vendor overview
Exhibit 55: BGI Genomics Co. Ltd. – Product segments
Exhibit 56: BGI Genomics Co. Ltd. – Organizational developments
Exhibit 57: BGI Genomics Co. Ltd. – Key offerings
Exhibit 58: Eurofins Scientific SE – Vendor overview
Exhibit 59: Eurofins Scientific SE – Business segments
Exhibit 60: Eurofins Scientific SE – Organizational developments
Exhibit 61: Eurofins Scientific SE – Segment focus
Exhibit 62: Eurofins Scientific SE – Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: GENEWIZ Inc. – Vendor overview
Exhibit 70: GENEWIZ Inc. – Product segments
Exhibit 71: GENEWIZ Inc. – Organizational developments
Exhibit 72: GENEWIZ Inc. – Key offerings
Exhibit 73: Novogene Corp. – Vendor overview
Exhibit 74: Novogene Corp. – Product segments
Exhibit 75: Novogene Corp. – Organizational developments
Exhibit 76: Novogene Corp. – Key offerings
Exhibit 77: Personalis Inc. – Vendor overview
Exhibit 78: Personalis Inc. – Business segments
Exhibit 79: Personalis Inc. – Organizational developments
Exhibit 80: Personalis Inc. – Key offerings
Exhibit 81: QIAGEN NV – Vendor overview
Exhibit 82: QIAGEN NV – Business segments
Exhibit 83: QIAGEN NV – Organizational developments
Exhibit 84: QIAGEN NV – Geographic focus
Exhibit 85: QIAGEN NV – Key offerings
Exhibit 86: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 87: Thermo Fisher Scientific Inc. – Business segments
Exhibit 88: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 89: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 90: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 91: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 92: Validation techniques employed for market sizing
Exhibit 93: Definition of market positioning of vendors



【掲載企業】

Agilent Technologies Inc., ArcherDx Inc., BGI Genomics Co. Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GENEWIZ Inc., Novogene Corp., Personalis Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 遺伝子パネルの世界市場:予測及び分析 2020-2024(Gene Panel Market by Product and Geography - Forecast and Analysis 2020-2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆